Structure of Type-I Mycobacterium tuberculosis fatty acid synthase at 3.3 Å resolution

被引:0
|
作者
Nadav Elad
Szilvia Baron
Yoav Peleg
Shira Albeck
Jacob Grunwald
Gal Raviv
Zippora Shakked
Oren Zimhony
Ron Diskin
机构
[1] Weizmann Institute of Science,Department of Chemical Research Support
[2] Weizmann Institute of Science,Department of Structural Biology
[3] Weizmann Institute of Science,Structural Proteomics Unit, Life Sciences Core Facilities
[4] Hebrew University,Kaplan Medical Center, Rehovot, affiliated to the School of Medicine
来源
Nature Communications | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Tuberculosis (TB) is a devastating and rapidly spreading disease caused by Mycobacterium tuberculosis (Mtb). Therapy requires prolonged treatment with a combination of multiple agents and interruptions in the treatment regimen result in emergence and spread of multi-drug resistant (MDR) Mtb strains. MDR Mtb poses a significant global health problem, calling for urgent development of novel drugs to combat TB. Here, we report the 3.3 Å resolution structure of the ~2 MDa type-I fatty acid synthase (FAS-I) from Mtb, determined by single particle cryo-EM. Mtb FAS-I is an essential enzymatic complex that contributes to the virulence of Mtb, and thus a prime target for anti-TB drugs. The structural information for Mtb FAS-I we have obtained enables computer-based drug discovery approaches, and the resolution achieved by cryo-EM is sufficient for elucidating inhibition mechanisms by putative small molecular weight inhibitors.
引用
收藏
相关论文
共 50 条
  • [31] MEDI 216-Saturation transfer difference NMR studies on the binding of the antitubercular agent pyrazinamide to Mycobacterium tuberculosis fatty acid synthase I
    Sayahi, H.
    Purramadappa, S.
    Ngo, S. C.
    Zimhony, O.
    Jacobs, W. R.
    Shekhtman, A.
    Welch, J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
  • [32] Structure and Inhibition of Tuberculosinol Synthase and Decaprenyl Diphosphate Synthase from Mycobacterium tuberculosis
    Chan, Hsiu-Chien
    Feng, Xinxin
    Ko, Tzu-Ping
    Huang, Chun-Hsiang
    Hu, Yumei
    Zheng, Yingying
    Bogue, Shannon
    Nakano, Chiaki
    Hoshino, Tsutomu
    Zhang, Lilan
    Lv, Pin
    Liu, Wenting
    Crick, Dean C.
    Liang, Po-Huang
    Wang, Andrew H. -J.
    Oldfield, Eric
    Guo, Rey-Ting
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (07) : 2892 - 2896
  • [33] FATTY ACID COMPOSITION OF PHOSPHATIDYL ETHANOLAMINE OF MYCOBACTERIUM TUBERCULOSIS
    SUBRAHMA.D
    INDIAN JOURNAL OF BIOCHEMISTRY, 1965, 2 (04): : 274 - &
  • [34] Pathogenicity of Type I Interferons in Mycobacterium tuberculosis
    Mundra, Akaash
    Yegiazaryan, Aram
    Karsian, Haig
    Alsaigh, Dijla
    Bonavida, Victor
    Frame, Mitchell
    May, Nicole
    Gargaloyan, Areg
    Abnousian, Arbi
    Venketaraman, Vishwanath
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [35] PHOSPHOLIPID AND FATTY-ACID COMPOSITION OF ERYTHROCYTES IN TYPE-I AND TYPE-II DIABETES
    FREYBURGER, G
    GIN, H
    HEAPE, A
    JUGUELIN, H
    BOISSEAU, MR
    CASSAGNE, C
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (07): : 673 - 678
  • [36] Structure of the human β-ketoacyl [ACP] synthase from the mitochondrial type II fatty acid synthase
    Christensen, Caspar Elo
    Kragelund, Birthe B.
    Von Wettstein-Knowles, Penny
    Henriksen, Anette
    PROTEIN SCIENCE, 2007, 16 (02) : 261 - 272
  • [37] Chemoenzymatic Generation of Phospholipid Membranes Mediated by Type I Fatty Acid Synthase
    Khanal, Satyam
    Brea, Roberto J.
    Burkart, Michael D.
    Devaraj, Neal K.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2021, 143 (23) : 8533 - 8537
  • [38] Probing the modularity of megasynthases by rational engineering of a fatty acid synthase Type I
    Rittner, Alexander
    Paithankar, Karthik S.
    Drexler, David Jan
    Himmler, Aaron
    Grininger, Martin
    PROTEIN SCIENCE, 2019, 28 (02) : 414 - 428
  • [39] Type I fatty acid synthase trapped in the octanoyl-bound state
    Rittner, Alexander
    Paithankar, Karthik S.
    Himmler, Aaron
    Grininger, Martin
    PROTEIN SCIENCE, 2020, 29 (02) : 589 - 605
  • [40] Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis
    Zimhony, O
    Cox, JS
    Welch, JT
    Vilchèze, C
    Jacobs, WR
    NATURE MEDICINE, 2000, 6 (09) : 1043 - 1047